John Orloff
2017
In 2017, John Orloff earned a total compensation of $3.6M as Executive Vice President, Head of Research & Development at Alexion Pharmaceuticals.
Compensation breakdown
| Bonus | $200,000 |
|---|---|
| Non-Equity Incentive Plan | $472,500 |
| Salary | $376,442 |
| Stock Awards | $2,499,995 |
| Other | $80,351 |
| Total | $3,629,288 |
Orloff received $2.5M in stock awards, accounting for 69% of the total pay in 2017.
Orloff also received $200K in bonus, $472.5K in non-equity incentive plan, $376.4K in salary and $80.4K in other compensation.
Rankings
In 2017, John Orloff's compensation ranked 2,897th out of 14,666 executives tracked by ExecPay. In other words, Orloff earned more than 80.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 2,897 out of 14,666 | 80th |
Division Manufacturing | 997 out of 5,772 | 83rd |
Major group Chemicals And Allied Products | 265 out of 2,075 | 87th |
Industry group Drugs | 202 out of 1,731 | 88th |
Industry Pharmaceutical Preparations | 160 out of 1,333 | 88th |
Source: SEC filing on March 26, 2019.
Orloff's colleagues
We found five more compensation records of executives who worked with John Orloff at Alexion Pharmaceuticals in 2017.
2017
Ludwig Hantson
Alexion Pharmaceuticals
Chief Executive Officer
2017
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
2017
Julie O'Neill
Alexion Pharmaceuticals
Former Executive Vice President of Global Operations
2017
Brian Goff
Alexion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2017
Anne-Marie Law
Alexion Pharmaceuticals